Suchergebnisse - "Rao, Martin"

PubPharm (10)

1

Evaluation of the efficacy of valproic acid and suberoylanilide hydroxamic acid (vorinostat) in enhancing the effects of first-line tuberculosis drugs against intracellular Mycobacterium tuberculosis

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2018

von Rao, M. | Valentini, D. | Zumla, A. | +1

2

Humoral immune profiling of mycobacterial antigen recognition in sarcoidosis and Löfgren's syndrome using high-content peptide microarrays

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2017

von Ferrara, G. | Valentini, D. | Rao, M. | +7

3

Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2017

von Valentini, D. | Rao, M. | Ferrara, G. | +4

4

Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis

enthalten in: BMC medicine | 2016

von Zumla, A. | Rao, M. | Dodoo, E. | +1

5

Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis

enthalten in: BMC medicine | 2016

von Zumla, A. | Rao, M. | Dodoo, E. | +1

6

Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis

enthalten in: BMC medicine | 2016

von Zumla, A. | Rao, M. | Dodoo, E. | +1

7

Host-directed therapies for infectious diseases: current status, recent progress, and future prospects

enthalten in: The lancet / Infectious diseases | 2016

von Zumla, A. | Rao, M. | Wallis, R. | +10

8

B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis

enthalten in: Clinical infectious diseases | 2015

von Rao, M. | Valentini, D. | Poiret, T. | +5

9

T-Cell Therapy: Options for Infectious Diseases

enthalten in: Clinical infectious diseases | 2015

von Parida, S. | Poiret, T. | Zhenjiang, L. | +11

10

B in TB: B cells as mediators of clinically relevant immune responses in tuberculosis

enthalten in: Clinical infectious diseases | 2015

von Rao, M. | Valentini, D. | Poiret, T. | +5

1
[1]